baber/WOPTO huggingface dataset:
Patent AU-2012361510-B2 (AU)
Title: Humanized anti-Epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
Inventor: SHIRAIWA HIROTAKE
IPC: A61P35/00
Filed: 2012-12-28
Granted: 2018-04-26
Abstract: The present inventors succeeded in producing an anti-Epiregulin antibody that exhibits a species crossreactivity between a non-human animal crab-eating monkey and a human animal, an anti-Epiregulin antibody that rarely undergoes chemical decomposition, an anti-Epiregulin antibody that has a decreased isoelectric point, an anti-Epiregulin antibody that has an elevated thermal denaturation midpoint temperature and an anti-Epiregulin antibody that is reduced in the amount of aggregates, by properly substituting an amino acid residue in the sequence for a variable region of a humanized EP27 antibody that can exhibit a cytotoxic activity and a neutralization activity on an anti-human Epiregulin-expressing cancer cell (i.e., a cancer cell that exhibits an anti-human Epiregulin) to thereby inhibit the proliferation of the cancer cell.
Patent AU-2012379922-B2 (AU)
Title: Catheter assembly
Inventor: TANABE HIDENORI
IPC: A61M5/158
Filed: 2012-05-16
Granted: 2017-07-20
Abstract: A catheter assembly (10) is provided with a protector (20) that when an inner needle (16) is extracted covers at least a needle tip (17) of the inner needle (16). The protector (20) has as inner cylinder (42) including an arm (46) that is releaseably connected to the base of a catheter hub (14) from the outside, and has an outer cylinder (62) inside of which the inner cylinder (42) is disposed and that is relatively displaceable in the axially line direction with respect to the inner cylinder (42). In the withdrawal operation for the inner needle (16), after the needle tip (17) of the inner needle (16) is stored in the protector (20), the outer cylinder (62) retracts with respect to the inner cylinder (42), and then as a result of the displacement of the arm (46) in the outward direction, the connection between the arm (46) and the catheter hub (14) is released.
Patent AU-2013201857-B2 (AU)
Title: Method and apparatus for encoding/decoding motion vector
Inventor: LEE TAMMY
IPC: H04N7/32
Filed: 2013-03-19
Granted: 2013-12-05
Abstract: Abstract Provided are methods and apparatuses for encoding and decoding a motion vector. The method of encoding the motion vector includes: selecting, as a mode of encoding information about a motion vector predictor of the current block, a first mode in which information indicating the motion vector predictor from among at least one motion vector predictor is encoded or a second mode in which information indicating generation of the motion vector predictor based on blocks or pixels included in a previously encoded area adjacent to the current block is encoded; determining the motion vector predictor of the current block according to the selected mode and encoding the information about the motion vector predictor of the current block; and encoding a difference vector between the motion vector of the current block and the motion vector predictor of the current block. C; r~PC0656dc
Patent AU-2013202895-B2 (AU)
Title: Rosuvastatin and atorvastatin derivatives
Inventor: LINDSAY DEREK
IPC: A61P9/10
Filed: 2013-04-08
Granted: 2014-09-18
Abstract: Abstract This invention relates to the discovery of novel rosuvastatin and atorvastatin analogues. Figure 1 .bP060 0.60 3 days E .05 days
Patent AU-2013204274-B2 (AU)
Title: Cardiac activation time detection
Inventor: HADDAD MILAD ABBAS EL
IPC: A61B5/04
Filed: 2013-04-12
Granted: 2014-10-09
Abstract: A method for characterizing an electrocardiogram, including receiving a first unipolar signal from a first location of a heart and a second unipolar signal from a second location of the heart. The method further includes generating a bipolar signal from the first and second unipolar signals, and analyzing the bipolar signal to delineate a time period during which the first and second locations generate a bipolar complex. The method also includes analyzing the first unipolar signal within the time period to determine an activation time of the first location. 2 of It <I U) U)l z C/ LuU LU <~ C\JC0 z~u 6 H a: Lu LU 0_ U)6 C/U) U)U) -J 0<0 uw 0 (00 LuU Hc 0c <0
Patent AU-2013206814-B2 (AU)
Title: Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
Inventor: YAO KENING
IPC: A01H5/00
Filed: 2013-07-11
Granted: 2016-01-21
Abstract: Plants, plant parts and plant seeds that are resistant to imidazolinone herbicides are provided. Plants are disclosed that contain a mutation in an AHAS gene. Specifically, plants are disclosed that contain a mutant AHAS gene allele of the Brassicajuncea B genome. Two B. juncea AHAS gene sequences (BjAHAS-a and BjAHAS-b) and one B. nigra AHAS gene sequence (BngrAHAS) are disclosed. The sequence of the mutant allele, BjAHAS-bR, is also disclosed. Various methods are disclosed that include creation of mutant B. juncea lines, selection for herbicide resistant lines and determining the presence of the BjAHAS-bR mutant allele after crosses. 4503796_1 (GHMatters) P71240.AU.2 11/07/13
Patent AU-2013211436-B2 (AU)
Title: Therapeutically active compounds and their methods of use
Inventor: LEMIEUX RENE M
IPC: A61K31/495
Filed: 2013-01-21
Granted: 2017-08-24
Abstract: Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.
Patent AU-2013216688-B2 (AU)
Title: Zinc finger nuclease-mediated homologous recombination
Inventor: CAI QIHUA
IPC: C12N15/82
Filed: 2013-08-16
Granted: 2015-09-17
Abstract: The invention relates to zinc finger nuclease-mediated homologous recombination.
Patent AU-2013223535-B2 (AU)
Title: Absorber and absorbent article using the same
Inventor: OTA YOSHIHISA
IPC: A61L15/60
Filed: 2013-02-20
Granted: 2016-04-07
Abstract: To provide an absorbent body and an absorbent article having excellent deodorization effect. The present invention provides an absorber comprising, a crosslinked polymer mainly composed of acrylic acid and having carboxyl groups thereof being at least partially neutralized as a water-absorbent resin powder, and an antibacterial cationic surfactant, wherein the antibacterial cationic surfactant is a compound neutralized with an acid having an acid dissociation constant pKa in water at 25 degrees centigrade in a range from 3.0 to 5.5.
Patent AU-2013225921-B2 (AU)
Title: Method and system for flotation separation in a magnetically controllable and steerable medium
Inventor: KERSEY ALAN D
IPC: B03D1/02
Filed: 2013-02-28
Granted: 2017-04-13
Abstract: The present invention provides new techniques related to magnetically controllable and/or steerable froth for use in separation processes of mineral-bearing ore and bitumen. Apparatus is provided featuring a processor configured to contain a fluidic medium having a material-of-interest and also having a surfactant with magnetic properties so as to cause the formation of a froth layer that contains at least some of the material-of-interest and is magnetically responsive; and a magnetic field generator configured to generate a magnetic field and provide non-mechanical mixing and steering/driving of the froth layer in the processor. The material-of-interest may be mineral-bearing ore particles or bitumen.
Patent AU-2013268732-B2 (AU)
Title: Battery case
Inventor: NAKAMORI YOJI
IPC: B60L11/18
Filed: 2013-05-17
Granted: 2015-11-19
Abstract: Provided is a battery case that is advantageous in improving durability of cables or connectors that are installed inside and outside of the battery case. When a structure such as an engine (14) or a fuel tank (16) installed next to the battery case (40) is displaced toward a tray (50) in the event of a collision of an electric car (10), both a short-side outer rim (5602) and a short-side sidewall (5802) come into contact with the structure. Thus, a triangular space (S) is secured between the structure and the tray (50). Consequently, an excessive force from the structure can be prevented from acting on the cable or the connectors, which is advantageous in improving durability of the cables and the connectors.
Patent AU-2013286683-B2 (AU)
Title: Therapeutic bisphosphonates
Inventor: WIEMER DAVID
IPC: A61P9/00
Filed: 2013-07-03
Granted: 2017-07-13
Abstract: The invention provides novel pyrophosphate synthase inhibitors of formula I and formula II as well salts thereof; the invention also provides compositions comprising such inhibitors and methods for their use.
Patent AU-2013298165-B2 (AU)
Title: Organo metal halide perovskite heterojunction solar cell and fabrication thereof
Inventor: ETGAR LIOZ
IPC: H01L51/42
Filed: 2013-07-24
Granted: 2020-02-20
Abstract: The present invention provides a solid state heterojunction solar cell comprising a transparent conducting support layer (2,3), on which a nanostructured, surface-increasing scaffold structure is provided, wherein an organic-inorganic perovskite layer (4) is provided on said scaffold structure, and wherein a counter electrode and/or metal layer (5) is provided in electric contact with said perovskite layer (4). According to an embodiment, the solar cell lacks an electrolyte or any hole conducting material. The invention also relates to a solid state ' heterojunction and to a method of preparing the solar cell.
Patent AU-2013308113-B2 (AU)
Title: Methods for producing cells having a phenotype of a primary human hepatocytes and compositions
Inventor: TYRRELL LORNE D
IPC: C12N5/071
Filed: 2013-08-30
Granted: 2019-01-17
Abstract: The present disclosure provides methods and compositions relating to in vitro cultures of human hepatocyte cell lines which exhibit a primary human hepatocyte phenotype. Such cell lines are susceptible to infection by a hepatotrophic virus, such as HCV or HBV, and support both viral replication and high levels of viral particle production. Such in vitro cultures find use in production and study of hepatotrophic virus, as well as methods of screening (e.g., for antiviral drugs, assessing drug metabolism), and study of primary human hepatocytes.
Patent AU-2013312953-B2 (AU)
Title: Modular welding wire feeder assembly
Inventor: MATIASH NICHOLAS A
IPC: B23K9/133
Filed: 2013-09-03
Granted: 2016-09-29
Abstract: A wire feeder comprises a motor and drive roll assembly. The motor and drive roll assembly comprises a base assembly having a left hand side and a right hand side. A first locating mechanism is on the right hand side and a second locating mechanism is on the left hand side. Modules, such as inlet or outlet guides can be located and mounted, preferably on either side. Each module preferably includes an additional locating mechanism to allow an additional module to be located by the additional locating mechanism. The locating mechanisms are preferably of the same design, and preferably each includes at least two holes with a locator pin disposed in each hole, and each module being located includes at least locating holes to receive the locator pins.
Patent AU-2013336801-B2 (AU)
Title: Filter segment comprising an acetate salt and glycerine
Inventor: GAMBS CELINE
IPC: A24D3/10
Filed: 2013-10-21
Granted: 2016-09-08
Abstract: A smoking article comprising a filter segment, the filter segment comprising a tow material and triacetin, wherein the filter segment further comprises an amino acid acetate salt and glycerine. The amino acid acetate salt and glycerine stabilise the triacetin in order to maintain the structural firmness of the tow material.
Patent AU-2014200731-B2 (AU)
Title: Material processing apparatus with multi-mode feed conveyor assembly
Inventor: DUNN GORDON
IPC: B02C21/02
Filed: 2014-02-11
Granted: 2018-05-17
Abstract: A material processing apparatus comprising: a base; a first material processing unit, for example a crusher; a feed conveyor; and a second 5 material processing unit, for example a screening unit. The feed conveyor and the second material processing unit are both movable with respect to the first material processing unit and with respect to each other so that material can be fed into the first material processing unit directly from the feed coneyor, or indirectly from the feed conveyor via the second material 10 processing unit. The second material processing unit can be stored beneath the feed conveyor when not in use. 415 e
Patent AU-2014218383-B2 (AU)
Title: Improvements in Phalloplasty
Inventor: MOORE COLIN CAMPBELL MARSHALL
IPC: A61F2/26
Filed: 2014-08-26
Granted: 2016-09-29
Abstract: A method of widening a penis wherein the penis is degloved, a graft is sutured to the exposed Bucks fascia and then reducing the penile skin; the method further including the step of following a post-operative treatment regime.
Patent AU-2014228568-B2 (AU)
Title: Laser capsulovitreotomy
Inventor: SCHUELE GEORG
IPC: A61F9/008
Filed: 2014-02-26
Granted: 2018-06-14
Abstract: Methods and systems for performing laser-assisted surgery on an eye form a layer of bubbles in the Berger's space of the eye to increase separation between the posterior portion of the lens capsule of the eye and the anterior hyaloid surface of the eye. A laser is used to form the layer of bubbles in the Berger's space. The increased separation between the posterior portion of the lens capsule and the anterior hyaloid surface can be used to facilitate subsequent incision of the posterior portion of the lens capsule with decreased risk of compromising the anterior hyaloid surface. For example, the layer of bubbles can be formed prior to performing a capsulotomy on the posterior portion of the lens capsule.
Patent AU-2014229361-B2 (AU)
Title: Deamorphization of spray-dried formulations via spray-blending
Inventor: WEERS JEFFRY
IPC: A61K9/16
Filed: 2014-03-11
Granted: 2016-08-04
Abstract: Dry powder formulations for inhalation and their use in the treatment diseases and conditions. The formulation contains a uniform blend of a first spray-dried powder and a second spray-dried powder. The first spray-dried powder contains spray-dried particles of a therapeutically active ingredient dispersed in a pharmaceutically acceptable hydrophobic excipient. The second spray-dried powder contains spray-dried particles formed from a pharmaceutically acceptable hydrophobic excipient but are substantially free of any therapeutically active ingredient. The active ingredient in the first spray-dried powder is loaded sufficiently high to compensate for the second spray-dried powder being substantially free of any active ingredient. A process for preparing such formulations is also described.
Patent AU-2014233653-B2 (AU)
Title: Spectrum management system and method
Inventor: SUN CHEN
IPC: H04B17/00
Filed: 2014-04-09
Granted: 2015-07-23
Abstract: A spectrum management system includes a circuit that identifies reference points for a secondary communication system. The spectrum management system then determines 5 spectrum resources for the secondary communication system based on whether the reference points are positive or negative. (fig. 1) -40-
Patent AU-2014250568-B2 (AU)
Title: Blast furnace operation method and lance
Inventor: FUJIWARA DAIKI
IPC: C21B5/00
Filed: 2014-03-27
Granted: 2016-09-15
Abstract: [Problem] To provide a blast furnace operation method and a lance making it possible to improve cooling power, improve the combustion quality of pulverized coal blown in from a tuyere, and reduce the unit consumption of the reducing agent. [Solution] A blast furnace operation method in which a solid reducing agent, a flammable gaseous reducing agent, and a combustion-sustaining gas are blown from a tuyere into the furnace through a lance, wherein: a parallel-type lance in which three independent blowing tubes are bundled in parallel and integrated with an outer tube is used; the gaseous reducing agent and/or the combustion-sustaining gas, and the solid reducing agent, are simultaneously blown in through the respective blowing tubes; and the blowing-in from the parallel-type lance is performed in an orientation in which the solid reducing agent blowing tube and the gaseous reducing agent blowing tube are positioned above the combustion-sustaining gas blowing tube. In addition, a lance structure used in the blast furnace operation method.
Patent AU-2014256399-B2 (AU)
Title: Catheter insertion device
Inventor: WOEHR KEVIN
IPC: A61M5/32
Filed: 2014-10-31
Granted: 2017-02-02
Abstract: H:\dxl\lntrovn\NRPortbl\DCC\DXL\6935969_I.doc-31/10/2014 A catheter insertion device comprising: a catheter hub comprising an interior cavity, an opening at a proximal end, and a catheter tube attached thereto and extending from a distal 5 end; a needle having a needle shaft defining a needle axis projecting distally of an end of a needle hub, said needle projecting through the catheter tube and comprising a needle tip; a valve sized and shaped to obstruct fluid flow through the catheter hub comprising a wall surface comprising a slit positioned inside the interior cavity of the catheter hub and abutting a shoulder in the interior cavity of the catheter hub; said valve remaining inside 10 the interior cavity when the needle is removed from the catheter tube and the catheter hub; a valve actuating element slidingly disposed in the catheter hub to actuate the valve, the valve actuating element comprising a nose section having a tapered end for pushing the valve to open the slit of the valve and at least two plunger elements extending proximally of the nose section and having a gap therebetween to permit fluid flow to flow 15 therethrough; the two plunger elements structured to transfer a distally directed force to the nose section to push the valve to open the slit; a needle protective device spaced from the needle tip in a ready position and movable relative to the needle tip to a protective position, at least in part, distally of the needle tip to prevent unintended needle sticks. coj _ 0- La I- j.C) La.
Patent AU-2014259948-B2 (AU)
Title: Accelerated healing of eye injuries by angiotensin peptides
Inventor: RODGERS KATHLEEN E
IPC: A61K38/08
Filed: 2014-04-30
Granted: 2019-04-18
Abstract: Disclosed herein are methods for treating eye injuries by administering one or more angiotensin peptides to a subject with an eye injury.
Patent AU-2014264567-B2 (AU)
Title: Hdpe
Inventor: BURYAK ANDREY
IPC: C08L23/06
Filed: 2014-05-09
Granted: 2017-08-03
Abstract: A multimodal polyethylene polymer having an MFR
Patent AU-2014265962-B2 (AU)
Title: Treatment of carbonaceous feedstocks
Inventor: BARTEK ROBERT
IPC: C07C51/16
Filed: 2014-05-14
Granted: 2018-05-31
Abstract: A method for treatment of a carbonaceous feedstock such as coal or black liquor is disclosed. The method comprises heating a mixture of the carbonaceous feedstock, with or without a solubilizing agent, water, and an oxidizing agent to solubilize and oxidize carbonaceous materials. In case of oxidation of black liquor, at least one organic compound comprising from about 2 to about 20 carbon atoms may be obtained. The reaction products may be chemically or physically separated, recycled to the heating step and/or subjected to microbial digestion in order to generate one or more desirable products from the carbonaceous feedstock.
Patent AU-2014284835-B2 (AU)
Title: Dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and composition for suppressing proliferation of dengue virus comprising RNA structure
Inventor: YANG JOO SUNG
IPC: A61K48/00
Filed: 2014-07-04
Granted: 2017-08-10
Abstract: The present invention relates to a dengue virus-specific siRNA, a high-efficiency double helix oligo-RNA structure comprising the siRNA, and a composition for suppressing the proliferation of dengue virus comprising the RNA structure. The double helix oligo-RNA structure has a structure in which a hydrophilic material and a hydrophobic material are grafted on both ends of a double helix RNA (siRNA) via a simple covalent bond or a linker-mediated covalent bond so that the double helix oligo-RNA structure is efficiently delivered into cells, and can be transformed into a nanoparticle type by a hydrophobic interaction of the double helix RNA structures in an aqueous solution. The siRNA included in the double helix oligo-RNA structure specifically acts on the serotype of all dengue viruses. In addition, the present invention relates to a method for preparing the double helix oligo-RNA structure, and a pharmaceutical composition containing the double helix oligo-RNA structure for preventing or treating a dengue virus infection.
Patent AU-2014334997-B2 (AU)
Title: Walkway installation, as well as a vessel with such a walkway installation
Inventor: KALKMAN PIETER
IPC: B63B27/14
Filed: 2014-10-14
Granted: 2017-11-23
Abstract: A walkway installation comprising a base (1) intended to be fastened to a support construction, such as to the deck (5) of a ship (6), as well as a base bridge part (2) that is connected at one end so it can be rotated around an upright base axis of rotation (11) with the base. Furthermore, a main bridge part (4) is provided on the other end of the base bridge part (1) as well as a hinge construction between the base bridge part (1) and the main bridge part (2). The hinge construction has an upright main axis of rotation (12) and an auxiliary axis of rotation (13) aligned transversely to the upright main axis of rotation and transversely to the main bridge part. By rotating the gangplank parts, the installation may be adjusted in a reliable and quick way in relation to a fixed object or another vessel.
Patent AU-2014358146-B2 (AU)
Title: Joint structure for steel pipe pile
Inventor: MATSUMIYA HIRONOBU
IPC: E02D5/24
Filed: 2014-12-04
Granted: 2017-01-05
Abstract: Provided is a joint structure for a steel pipe pile that coaxially connects a first steel pipe pile and a second steel pipe pile and wherein: an outer fitting valley section is formed so that the plate thickness thereof increases the closer an outer fitting stepped section is to the first steel pipe pile; an inner fitting valley section is formed so that the plate thickness thereof increases the closer an inner fitting stepped section is to the second steel pipe pile; and, in a state in which an inner fitting end section is inserted in an outer fitting end section, rotated relative to the outer fitting end section, and fitted thereto, an inner fitting tip surface and the surface that faces this inner fitting tip surface are separated by a predetermined distance (D) and the overall surface area of a tension-side contact surface that is made to bear tensile force is equal to or less than the total surface area of the surface area of the outer fitting tip surface that bears compressive force and the overall surface area of a compression-side contact surface that bears compressive force.
Patent AU-2014364823-B2 (AU)
Title: Low voc gibberellin formulations
Inventor: DEVISETTY BALA N
IPC: A01N43/12
Filed: 2014-12-17
Granted: 2018-03-01
Abstract: The invention relates to low volatile organic chemical gibberellic acid ("GA
Patent AU-2014371148-B2 (AU)
Title: (6S,9aS)-N-Benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
Inventor: INOUE SATOSHI
IPC: A61K31/53
Filed: 2014-12-22
Granted: 2018-08-09
Abstract: Provided is a compound represented by general formula (1) or a pharmaceutically acceptable salt thereof. [In the formula, R